Field Trip Health Ltd.
FTRP · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $2 | $1 | $1 |
| % Growth | -100% | 26.7% | 49.9% | – |
| Cost of Goods Sold | $0 | $3 | $3 | $2 |
| Gross Profit | $0 | -$1 | -$1 | -$1 |
| % Margin | – | -56.1% | -87.1% | -111.3% |
| R&D Expenses | $3 | $2 | $1 | $2 |
| G&A Expenses | $2 | $8 | $10 | $9 |
| SG&A Expenses | $2 | $8 | $11 | $11 |
| Sales & Mktg Exp. | $0 | -$0 | $1 | $1 |
| Other Operating Expenses | $0 | $1 | $1 | $1 |
| Operating Expenses | $5 | $12 | $13 | $14 |
| Operating Income | -$13 | -$14 | -$15 | -$15 |
| % Margin | – | -800.3% | -1,076.4% | -1,622.7% |
| Other Income/Exp. Net | $8 | -$0 | -$0 | $2 |
| Pre-Tax Income | -$5 | -$14 | -$15 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5 | -$15 | -$15 | -$13 |
| % Margin | – | -843.6% | -1,123.6% | -1,434.1% |
| EPS | -0.45 | -1.26 | -1.32 | -1.13 |
| % Growth | 64.3% | 4.5% | -16.8% | – |
| EPS Diluted | -0.45 | -1.26 | -1.32 | -1.13 |
| Weighted Avg Shares Out | 12 | 12 | 12 | 11 |
| Weighted Avg Shares Out Dil | 12 | 12 | 12 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$4 | -$13 | -$14 | -$12 |
| % Margin | – | -735.1% | -1,001.9% | -1,312.4% |